{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(1)"],"submitter":["Maria-Ferreira D"],"pubmed_abstract":["Natural polysaccharides have emerged as an important class of bioactive compounds due their beneficial biological effects. Here we investigated the protective and healing effects of rhamnogalacturonan (RGal) isolated from Acmella oleracea (L.) R.K. Jansen leaves in an experimental model of intestinal inflammation in mice and in heterogeneous human epithelial colorectal adenocarcinoma cells (Caco-2). The findings demonstrated that RGal treatment for 7 days reduced the severity of DSS-induced colitis by protecting mice from weight loss, macroscopic damage and reduction of colon length. When compared to the DSS group, RGal also protected the colon epithelium and promoted the maintenance of mucosal enterocytes and mucus secreting goblet cells, in addition to conserving collagen homeostasis and"],"journal":["Scientific reports"],"pagination":["12261"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6095889"],"repository":["biostudies-literature"],"pubmed_title":["Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells."],"pmcid":["PMC6095889"],"pubmed_authors":["Cipriani TR","van den Wijngaard RM","Nascimento AM","Sant Ana DMG","Maria-Ferreira D","Werner MFP","Baggio CH","Luciano FB","Bocate KCP","Santana-Filho AP","Watanabe PDS"],"additional_accession":[]},"is_claimable":false,"name":"Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells.","description":"Natural polysaccharides have emerged as an important class of bioactive compounds due their beneficial biological effects. Here we investigated the protective and healing effects of rhamnogalacturonan (RGal) isolated from Acmella oleracea (L.) R.K. Jansen leaves in an experimental model of intestinal inflammation in mice and in heterogeneous human epithelial colorectal adenocarcinoma cells (Caco-2). The findings demonstrated that RGal treatment for 7 days reduced the severity of DSS-induced colitis by protecting mice from weight loss, macroscopic damage and reduction of colon length. When compared to the DSS group, RGal also protected the colon epithelium and promoted the maintenance of mucosal enterocytes and mucus secreting goblet cells, in addition to conserving collagen homeostasis and","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Aug","modification":"2026-07-16T01:42:33.163Z","creation":"2019-03-26T23:51:46Z"},"accession":"S-EPMC6095889","cross_references":{"pubmed":["30115942"],"doi":["10.1038/s41598-018-30526-2"]}}